scout
News|Videos|November 22, 2023

Updated NCCN Guidelines for the Treatment of Advanced or Recurrent Endometrial Cancer

Key opinion leaders review recent updates to the NCCN guidelines for treating recurrent and advanced endometrial cancer, including biomarker testing and targeted therapies like dostarlimab and trastuzumab.

Episodes in this series

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME